Itau Unibanco Holding S.A. Guardant Health, Inc. Transaction History

Itau Unibanco Holding S.A.

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 13, 2024	BUY	$16.07 - $31.84 $4,419 - $8,756	275 New	275 $7,000
Q4 2023 Feb 14, 2024	BUY	$21.58 - $29.5 $24,579 - $33,600	1,139 Added 66.14%	2,861 $77,000
Q3 2023 Nov 14, 2023	SELL	$25.8 - $39.97 $180 - $279	-7 Reduced 0.4%	1,722 $51,000
Q2 2023 Aug 14, 2023	SELL	$20.94 - $38.01 $649 - $1,178	-31 Reduced 1.76%	1,729 $61,000
Q4 2022 Feb 09, 2023	BUY	$25.44 - $59.78 $18,240 - $42,862	717 Added 68.74%	1,760 $47,000
Q3 2022 Nov 14, 2022	SELL	$43.66 - $61.0 $11,438 - $15,982	-262 Reduced 20.08%	1,043 $56,000
Q2 2022 Aug 15, 2022	BUY	$28.82 - $77.35 $172 - $464	6 Added 0.46%	1,305 $53,000
Q1 2022 May 16, 2022	BUY	$48.25 - $100.49 $289 - $602	6 Added 0.46%	1,299 $86,000
Q4 2021 Feb 14, 2022	BUY	$88.71 - $120.43 $77,887 - $105,737	878 Added 211.57%	1,293 $130,000
Q3 2021 Nov 12, 2021	BUY	$98.77 - $132.17 $1,086 - $1,453	11 Added 2.72%	415 $52,000
Q2 2021 Aug 17, 2021	BUY	$109.77 - $165.68 $44,347 - $66,934	404 New	404 $50,000

323

127M

844K

2.38M

Ticker GH
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 102,220,000
Market Cap $3.34B
Description
Guardant Health, Inc., a precision oncology company, provides blood tests, data sets, and analytics in the United States and internationally. The company offers Guardant360, Guardant360 LDT, Guardant360 CDx, and GuardantOMNI liquid biopsy-based tests for advanced stage cancer; and GuardantINFORM, an in-silico research platform that comprise a cl...

Get notified when there are updates to the investment portfolio of Itau Unibanco Holding S.A., based on Form 13F filings with the SEC.

Stay updated on Itau Unibanco Holding S.A. with notifications on news.